Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Dermatology | Family Medicine | Geriatrics | Nursing | Journal

Back to Journal Articles

Hypertrophy Common in Older Patients With Port-Wine Stains

Last Updated: July 13, 2012.

 

Median age of onset 31 years; 71 percent of patients older than 50 years have hypertrophy

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Hypertrophy is present in the majority of patients with port-wine stains who are over the age of 50 years, according to a study published online July 2 in the Journal of the American Academy of Dermatology.

FRIDAY, July 13 (HealthDay News) -- Hypertrophy is present in the majority of patients with port-wine stains (PWS) who are over the age of 50 years, according to a study published online July 2 in the Journal of the American Academy of Dermatology.

Anne Margreet van Drooge, M.D., from the University of Amsterdam, and colleagues retrospectively analyzed medical records and clinical photographs of all patients with PWS visiting a clinic between 2005 and 2009. Three hundred thirty-five participants (age range, 0 to 81 years; 69 percent female) responded to a questionnaire regarding hypertrophic PWS.

The researchers identified hypertrophy in 20 percent of PWS patients, which was classified as thickened (5 percent), nodular (8 percent), or both (7 percent). The color of hypertrophic PWS was mainly red or purple (50 and 44 percent, respectively). Sixty-eight percent of patients with hypertrophy in their PWS were older than 40 and only 7 percent were younger than 20 years. Of the patients older than 50 years, 71 percent had hypertrophy in their PWS. The median age of hypertrophy onset was 31 years -- 12 years for thickened hypertrophy and 39 years for nodular hypertrophy.

"This study shows that hypertrophy is a common development in PWS, affecting 20 percent of all patients with PWS and 71 percent of patients older than 50 years," the authors write. "Patients should be informed about the natural course of PWS and more attention needs to be drawn to therapy and prevention of hypertrophic PWS."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Triage Decisions Differ for Paramedics and Physicians Next: Chemo Combo Promising for Pancreatic Neuroendocrine Tumors

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.